Research Topics
| T J SeboSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancyRichard A Ashley
Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Cancer 107:712-20. 2006..The authors recommend using the Mayo staging system in future studies because of its simplicity. The current results indicated that the most important predictors of prognosis were tumor grade and surgical margin status...
What are the keys to successful thyroid FNA interpretation?Thomas J Sebo
Anatomic Pathology, Division of Laboratory Medicine and Pathology, Mayo Clinic, and Mayo Medical School, Rochester, MN 55905, USA
Clin Endocrinol (Oxf) 77:13-7. 2012..S. adult population in comparison with the risk of dying of thyroid malignancy, the main role of TFNAB is to reduce the need for surgical intervention...
Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative seruT J Sebo
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 91:2196-204. 2001....
Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancerThomas J Sebo
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 26:431-9. 2002..Cancer progression models that include serum prostate specific antigen and clinical stage may require revision to incorporate perineural invasion and MIB-1 proliferative activity in addition to Gleason score...
Serous borderline tumor of the paratestis: a report of seven casesR F McClure
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 25:373-8. 2001..To date, no serous borderline tumor of the paratestis reported in the literature or in our series has recurred or metastasized after resection...
Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4W K Lau
Department of Urology, Laboratory Medicine and Pathology, Section of Biostatistics, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 166:1692-7. 2001..However, primary Gleason grade does not provide any additional information than other known prognostic factors, such as preoperative PSA, seminal vesicle invasion and DNA ploidy...
Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 casesJ E Lewis
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
Hum Pathol 32:596-604. 2001..Intracapsular carcinoma has a benign clinical course. Significant prognostic factors in CXPA include tumor stage, grade, proportion of carcinoma, extent of invasion, and proliferation index...
Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysisA Rumalla
Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 76:29-33. 2001..CONCLUSION: Ploidy assessment by DIA has potential to enhance the sensitivity of diagnosing malignant strictures compared with routine cytology alone...
Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinomaN S Buttar
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic and Graduate School of Medicine, Rochester, Minnesota, USA
Gastroenterology 120:1630-9. 2001..02) on multivariate analysis. CONCLUSIONS: Patients with focal HGD are less likely to have cancer during the first year after diagnosis or on subsequent follow-up compared with diffuse HGD...
p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggressionS J Kausik
Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
J Urol 169:1815-7. 2003..3) or prognosis (p >0.3) in individuals with histologically favorable Wilms tumor assessed for immunopositivity before administration of chemotherapy...
Endometrial cancer: can nodal status be predicted with curettage?Andrea Mariani
Section of Gynecologic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Gynecol Oncol 96:594-600. 2005..To determine whether histologic or molecular markers assessed in pretreatment curettage specimens predict nodal metastasis in endometrial cancer...
BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroidLong Jin
Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street, SW. Rochester, MN 55905, USA
Diagn Mol Pathol 15:136-43. 2006..However, the allele-specific LC PCR with CYBR green 1 method is most rapid, easier to perform, and least expensive technique, and it can be readily performed in most molecular diagnostic laboratories...
Can the kidney function as a lung? Systemic oxygenation and renal preservation during retrograde perfusion of the ischaemic kidney in rabbitsMitchell R Humphreys
Department of Urology, Mayo Clinic, Rochester, MN, USA
BJU Int 98:674-9. 2006....
Pathobiology of pituitary adenomas and carcinomasBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Neurosurgery 59:341-53; discussion 341-53. 2006....
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trialSteven R Alberts
Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Am J Ther 13:291-7. 2006..Quality-of-life measures did not show any differences between the 2 groups. This study showed no evidence of benefit from flutamide as a chemoprevention agent in men with HGPIN...
Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomyShomik Sengupta
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Urology 68:94-8. 2006..CONCLUSIONS: The results of our study have shown that the likelihood of +SMs at RRP is best predicted on the basis of conventional prognostic factors. The DIA features of needle biopsies did not provide additional predictive power...
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001Shomik Sengupta
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 106:2630-5. 2006..A chronological change in pathologic grading classification is suggested by evolving prognostic implications, which must be accounted for when comparing outcomes from different eras...
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-upR Houston Thompson
Department of Urology, Mayo Medical School, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cancer Res 66:3381-5. 2006..RCC patients with tumor B7-H1 are at significant risk of rapid cancer progression and accelerated rates of mortality. B7-H1 may function as a key determinant in RCC, abrogating immune responses directed against this immunogenic tumor...
Salvage surgery for radiorecurrent prostate cancer: contemporary outcomesJohn F Ward
Division of Urology, Department of Surgery, Naval Medical Center, Portsmouth, Virginia, USA
J Urol 173:1156-60. 2005..We present a 30-year experience with performing salvage surgery in patients with persistent prostate cancer (PCA) after definitive radiotherapy...
p300 modulates nuclear morphology in prostate cancerJose D Debes
Department of Urology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Cancer Res 65:708-12. 2005..These findings reveal a new insight into the transcriptional and structural regulation of prostate cancer...
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen eraDavid S Dimarco
Department of Urology, Mayo Clinic, Rochester, Minnesota 55901, USA
J Urol 173:1121-5. 2005..These results suggest that under staging is not present in apparently node negative cases with limited lymphadenectomy and, even if present, its impact on outcome is likely to be negligible...
Sonography of thyroid nodules: a "classic pattern" diagnostic approachCarl C Reading
Department of Radiology, Division of Ultrasonography, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Ultrasound Q 21:157-65. 2005..These appearances include specific nodules that commonly need fine needle aspiration (FNA)/biopsy, and other nodules that do not usually need FNA/biopsy...
Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomyBrant A Inman
Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Urology 68:604-8. 2006..Controversy exists as to which form of therapy is most effective for high-grade prostate cancer (PCa)...
Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapyShomik Sengupta
Department of Urology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Urology 68:810-4. 2006..Prospective assessment of oncologic outcomes of such an approach is required...
Advanced cytologic techniques for the detection of malignant pancreatobiliary stricturesLaura E Moreno Luna
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Gastroenterology 131:1064-72. 2006..CONCLUSIONS: These findings suggest that FISH and DIA increase the sensitivity for the diagnosis of malignant pancreatobiliary tract strictures over that obtained by conventional cytology while maintaining an acceptable specificity...
Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative careRory L Smoot
Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
J Am Coll Surg 207:368-70. 2008..Previous literature has reported dismal survival for these patients. We examined our single-institution experience with this tumor to compare survival for sugical resection and palliative therapy...
A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagusEmily G Barr Fritcher
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Hum Pathol 39:1128-35. 2008..Additional studies are needed to further evaluate the clinical use of FISH...
Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct stricturesMichael J Levy
Division of Gastroenterology and Hepatology, Mayo Clinic Foundation, Rochester, Minnesota, USA
Am J Gastroenterol 103:1263-73. 2008..Our aim was to prospectively evaluate the accuracy of these techniques in patients with indeterminate biliary strictures...
B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrenceJonathan C Routh
Department of Urology, Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minnesota, USA
J Urol 179:1954-9; discussion 1959-60. 2008..We hypothesize that this finding may be true for Wilms tumor...
Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNAMichael J Levy
Division of Gastroenterology and Hepatology, Department of Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Gastrointest Endosc 66:483-90. 2007..These tumor markers have not been applied to EUS-guided FNA...
Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumorsWilliam R Sukov
Mayo Clinic, Pathology, Rochester, MN 55905, USA
Hum Pathol 38:1432-7. 2007....
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapyTimothy J Roth
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer Res 67:7893-900. 2007..Moreover, B7-H3 encompasses a novel diagnostic and potential therapeutic target for the clinical management of prostate cancer and, perhaps, other malignancies as well...
Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastasesChristine L H Snozek
Department of Laboratory Medicine, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 92:4278-81. 2007..Furthermore, the combination of undetectable serum Tg and an innocuous ultrasound might altogether obviate the need for biopsy...
Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinomaAmy E Krambeck
Department of Urology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA
Clin Cancer Res 13:1749-56. 2007..Herein, we examine the clinical effect of ccRCC combined expression of both survivin and B7-H1...
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progressionBrant A Inman
Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Cancer 109:1499-505. 2007..The role of PD-L1 was evaluated as a mechanism for local stage progression in urothelial carcinoma (UC) of the bladder...
Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidneySamson W Fine
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Am J Surg Pathol 30:1554-60. 2006..Pathologists must be aware of the spectrum of histologic findings within MTSCs to ensure their accurate diagnosis...
Hyalinizing trabecular adenoma of the thyroid gland identification through MIB-1 staining of fine-needle aspiration biopsy smearsMary B Casey
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Am J Clin Pathol 122:506-10. 2004..Hyalinizing trabecular adenoma can be distinguished reliably from other thyroid neoplasms by MIB-1 staining of destained cells from FNA biopsy specimens...
PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic valueMustafa Sahin
Department of Medicine, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 90:463-8. 2005..g. during intraoperative frozen section). PPARgamma staining also shows an association with favorable prognosis and may have a role in risk stratification...
Dedifferentiation in low-grade mucoepidermoid carcinoma of the parotid glandToshitaka Nagao
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
Hum Pathol 34:1068-72. 2003..It is important to recognize that dedifferentiation can occur in a low-grade MEC, similar to other low-grade salivary gland carcinomas...
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcomeKent G Krejci
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Urology 62:641-6. 2003..Tumor stage and grade were associated with outcome among patients with localized clear cell RCC. These findings are similar to the results for patients with localized clear cell RCC treated with radical nephrectomy...
Microsatellite instability in hereditary and sporadic breast cancersCamilo Adem
1Division of Laboratory Genetics, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
Int J Cancer 107:580-2. 2003..Mismatch repair gene mutations may be secondary random events in breast cancer progression...
Adenomatoid tumor of the adrenal gland: a clinicopathologic study of five cases and review of the literaturePhillip A Isotalo
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 27:969-77. 2003..6%). In three cases with clinical follow-up, no recurrence or metastases occurred. Adrenal gland adenomatoid tumors are morphologically and immunophenotypically identical to adenomatoid tumors of the genital tract and appear benign...
Identifying and quantifying apoptosis: navigating technical pitfallsMegan M Garrity
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Mod Pathol 16:389-94. 2003..Our data show that the advantages offered by the BLISS imaging software greatly reduce the potential drawbacks of using the TUNEL method as a sole means of quantification...
Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adultsChristopher B Dechet
Department of Urology, Division of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Urol 169:71-4. 2003..Rather, cases must be decided individually...
Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomySankar J Kausik
Department of Urology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Cancer 95:1215-9. 2002..The benefit of adjuvant therapy in optimizing recurrence-free survival remains to be tested...
Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survivalJohn C Cheville
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 95:1028-36. 2002..The objective of this study was to examine the clinical and pathologic features of metastatic prostate carcinoma to bone in a large cohort of men, and the associations of these features with outcome...
pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survivalJohn C Cheville
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 94:2180-4. 2002....
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urineKevin C Halling
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN, USA
J Urol 167:2001-6. 2002..However, further studies are needed to explore the role of the various assays in the treatment of patients with superficial urothelial carcinoma...
Comparison of quantitative histomorphometry and DNA ploidy in tissue sections of prostate carcinomaPaul A Kay
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Anal Quant Cytol Histol 24:7-14. 2002..Quantitative histomorphometry has potential as a method of rapidly assessing DNA ploidy otherwise earmarked for nuclear image analysis, resulting in savings of time and expense...
Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcomaScott A Martin
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 26:292-300. 2002..In addition, the diagnosis of urinary bladder leiomyoma should be reserved for noninfiltrative smooth muscle tumors lacking mitotic activity, cytologic atypia, and necrosis...
p300 in prostate cancer proliferation and progressionJose D Debes
Departments of Urology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Cancer Res 63:7638-40. 2003..We conclude that p300 plays an important role in PCa cell proliferation, as well as PCa progression...
Molecular and histopathologic predictors of distant failure in endometrial cancerAndrea Mariani
Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cancer Detect Prev 27:434-41. 2003..01). Thus, locoregional therapy may be insufficient when at least one of these predictors is present...
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvementIgor Frank
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 101:1803-8. 2004..The objective of this study was to assess the ability of these markers to predict disease-associated outcomes and response to chemotherapy in a cohort of patients with LN-positive TCC...
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinomaRicardo V Lloyd
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Am J Surg Pathol 28:1336-40. 2004..Since most cases with metastatic disease had obvious invasion, caution should be used in making a diagnosis of FVPCA in the absence of the major histopathologic features or clear-cut invasive growth...
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct stricturesBenjamin R Kipp
Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Am J Gastroenterol 99:1675-81. 2004..FISH may improve the clinical management of patients who are being evaluated for malignancy in bile duct strictures...
Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretationGavin C Harewood
Division of Gastroenterology and Hepatology, Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Gastroenterol 99:1464-9. 2004..The knowledge of the patient's clinical information appears to clarify cytology interpretation resulting in fewer equivocal results. We did not detect any reliable predictors of cytology accuracy...
Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 casesMary B Casey
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Am J Surg Pathol 28:859-67. 2004....
Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four casesThomas A Gaffey
Mayo Clinic, Rochester, Minnesota 55902, USA
J Neurosurg 96:352-60. 2002....
Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or lessDavid S Dimarco
Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
Urol Oncol 21:439-46. 2003..Percent surface area predicted EPE at RRP. DNA ploidy and MIB-I proliferation by DIA did not provide additional information...
Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?John F Ward
Mayo Clinic, Department of Urology, Rochester, MN, USA
Urol Oncol 22:40-7. 2004....
B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observationsMarie Christine Aubry
Division of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cardiovasc Pathol 13:233-6. 2004..To describe the subtypes of lymphocytes in coronary arteries of two patients with rheumatoid arthritis (RA) and coronary artery disease (CAD)...
An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarraysSchuyler O Sanderson
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Am J Clin Pathol 121:220-5. 2004..The p63/P504S immunohistochemical stain is a sensitive, specific marker for prostatic adenocarcinoma and HPIN and useful in the evaluation of AASA in biopsy specimens...
A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract stricturesTodd H Baron
Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Gastroenterol Hepatol 2:214-9. 2004..Digital image analysis (DIA) allows quantification of nuclear DNA content and may help distinguish benign and malignant strictures of the biliary tract...
Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladderWilliam R Sukov
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55902, USA
Mod Pathol 20:592-603. 2007....
Increased optical magnification from 2.5x to 4.3x with technical modification lowers the positive margin rate in open radical retropubic prostatectomyJames S Magera
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 179:130-5. 2008..We compared the positive surgical margin rate of 2.5x and 4.3x optical loupe magnification with associated technical improvement during open radical retropubic prostatectomy...
Histiocytes containing immunoglobulin crystals in the urine of a patient with IgA kappa plasmacytoma of the bladderDylan V Miller
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Diagn Cytopathol 31:48-51. 2004..This was supported by immunocytochemical staining...
Primary squamous cell carcinoma of the thyroid: report of ten casesFargol Booya
Division of Endocrinology, Diabetes, Nutrition and Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Thyroid 16:89-93. 2006..The prognosis for patients with PSCCT is worse than SSCCT. p21, MIB-I, and p53 are overexpressed in PSCCT. Thyroglobulin and TTF can show focal positivity in PSCCT distinguishing it from SSCCT...
Galectin-3 expression in hyalinizing trabecular tumors of the thyroid glandRobyn L Gaffney
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Am J Surg Pathol 27:494-8. 2003..Our study suggests that the variable pattern of galectin-3 expression may reflect a difference in biologic behavior between HTT and papillary thyroid carcinoma...
Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancyEmily G Barr Fritcher
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN, USA
Am J Clin Pathol 128:272-9. 2007..The low sensitivity of cytologic examination for pancreatobiliary carcinoma is due to an absence of tumor cells or the presence of well-differentiated tumor lacking recognizable nuclear atypia...
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriersCamilo Adem
Division of Laboratory Genetics, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
Cancer 97:1-11. 2003..This increased progression rate should be taken into account when considering the surveillance of asymptomatic women...
